ANAPTYSBIO INC. - COMMON STOCK
20.32
14-November-24 09:37:42
15 minutes delayed
Stocks
-0.43
-2.07%
Today's range
20.25 - 21.31
ISIN
N/A
Source
NASDAQ
-
Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update
05 Nov 2024 15:15:00 By Nasdaq GlobeNewswire
-
Anaptys Announces Participation in November and December Investor Conferences
05 Nov 2024 15:15:00 By Nasdaq GlobeNewswire
-
Anaptys Announces Participation in September Investor Conferences
29 Aug 2024 08:15:00 By Nasdaq GlobeNewswire
-
Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
14 Aug 2024 04:00:00 By Nasdaq GlobeNewswire
-
Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update
05 Aug 2024 15:15:00 By Nasdaq GlobeNewswire
-
Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update
09 May 2024 15:15:00 By Nasdaq GlobeNewswire
-
09 May 2024 15:10:00 By Nasdaq GlobeNewswire
-
09 May 2024 15:05:01 By Nasdaq GlobeNewswire
-
Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
11 Mar 2024 15:15:00 By Nasdaq GlobeNewswire
-
Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual Meeting
29 Feb 2024 08:15:00 By Nasdaq GlobeNewswire
-
Anaptys to Present at Guggenheim’s 6th Annual Biotechnology Conference
31 Jan 2024 08:15:00 By Nasdaq GlobeNewswire
-
27 Nov 2023 15:15:00 By Nasdaq GlobeNewswire
-
Anaptys Named a BioSpace 2024 Best Places to Work Winner
07 Nov 2023 15:15:00 By Nasdaq GlobeNewswire
-
Anaptys Announces Third Quarter 2023 Financial Results and Provides Business Update
02 Nov 2023 15:15:00 By Nasdaq GlobeNewswire
-
Anaptys Announces Participation in November Investor Conferences
01 Nov 2023 08:15:00 By Nasdaq GlobeNewswire
-
Anaptys to Present Phase 1 Data on ANB032, its BTLA Agonist Antibody, at the 32nd EADV Congress
11 Oct 2023 08:15:00 By Nasdaq GlobeNewswire
-
09 Oct 2023 07:15:00 By Nasdaq GlobeNewswire
-
09 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors
18 Sep 2023 15:15:00 By Nasdaq GlobeNewswire
-
AnaptysBio to Present at the Stifel 2023 Immunology and Inflammation Virtual Summit
12 Sep 2023 08:15:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >